CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh(Saarland University), Lorenz Trümper(University of Göttingen), Anders Österborg(Karolinska University Hospital), Ruth Pettengell(St George's Hospital), Marek Trněný(Charles University), Kevin Imrie(Sunnybrook Health Science Centre), Dávid Ma(St Vincent's Hospital Sydney), Devinder Gill(Princess Alexandra Hospital), Jan Walewski, Pier Luigi Zinzani(Istituto Oncologico Romagnolo), Rolf A. Stahel(University Hospital of Zurich), Stein Kvaløy(Norwegian Cancer Society), Ofer Shpilberg(Soroka Medical Center), Ulrich Jaeger(Vienna General Hospital), Mads Hansen(Rigshospitalet), Tuula Lehtinen(Savonlinna Central Hospital), Armando López‐Guillermo, Claudia Corrado(Fundación para la Investigación, Docencia y Prevención del Cáncer), Adriana Scheliga(Instituto Nacional de Câncer - INCA), Nöel Milpied(École Centrale de Nantes), Myriam Mendila(Roche (Switzerland)), Michelle Rashford(Roche (Switzerland)), Evelyn Kuhnt, Markus Loeffler(Leipzig University)
Cited by 2,081
Abstract
Related Papers
No related papers found
Powered by citation graph analysis